Fernando Ferrer, MD in Avon, CT - Medicare Urology

Fernando Ferrer, MD is a medicare enrolled "Urology - Pediatric Urology" physician in Avon, Connecticut. His current practice location is 100 Simsbury Rd, Suite 208, Avon, Connecticut. You can reach out to his office (for appointments etc.) via phone at (860) 409-0413.

Fernando Ferrer is licensed to practice in Connecticut (license number 035121) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1740253483.

Contact Information

	Fernando Ferrer, MD
	100 Simsbury Rd, Suite 208, Avon, CT 06001-3793
	(860) 409-0413
	(860) 499-5418

Physician's Profile

Full Name	Fernando Ferrer
Gender	Male
Speciality	Urology - Pediatric Urology
Location	100 Simsbury Rd, Avon, Connecticut
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1740253483
Provider Enumeration Date: 02/13/2006
Last Update Date: 02/28/2017

Medicare PECOS Information:

PECOS PAC ID: 2769587450
Enrollment ID: I20160928002490

Medical Identifiers

Medical identifiers for Fernando Ferrer such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1740253483	NPI	-	NPPES
001351212	Medicaid	CT

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208800000X	Urology	035121 (Connecticut)	Secondary
2088P0231X	Urology - Pediatric Urology	035121 (Connecticut)	Primary
2088P0231X	Urology - Pediatric Urology	286455 (New York)	Secondary
208800000X	Urology	286455 (New York)	Secondary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Fernando Ferrer allows following entities to bill medicare on his behalf.

Entity Name	Pediatric Urology Associates, Pc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1518989193 PECOS PAC ID: 5597656561 Enrollment ID: O20040322000453

News Archive

Chemists rationally design inhibitors against an RNA molecule that causes myotonic muscular dystrophy

Chemists at the University at Buffalo have used rational drug design to synthesize small, cell-permeable molecules that are effective in vitro against two common types of myotonic muscular dystrophy, a result that has implications for potentially curing muscular dystrophy, as well as other diseases.

U.S. District Court Judge approves amended settlement in WTC litigation

At the conclusion of a hearing today, Judge Alvin K. Hellerstein of the U.S. District Court for the Southern District of New York signed an order approving the amended settlement reached among the WTC Captive Insurance Company (the "WTC Captive"), the City of New York, the contractors the City hired, their subcontractors, and attorneys for over 10,000 plaintiffs alleging injuries from the WTC site operations.

Dendritic-specific Golgi plays key role in early neuropathy of degenerative brain disease

A joint research team of DGIST have identified the early neuropathic mechanism of polyglutamine brain disease, one of the representative degenerative brain diseases, and suggested a way to restore.

Bees-Haus method of cell therapy for treating urethral stricture receives Japanese patent

Treating male urethral stricture with the patient's own buccal mucosal cells, encapsulated in a polymer scaffold as carrier, has been granted a patent in Japan.

Scientists can produce new proteins by following certain rules

By following certain rules, scientists can prepare architectural plans for building ideal protein molecules not found in the real world. Based on these computer renditions, previously non-existent proteins can be produced from scratch in the lab. The principles to make this happen appear this month in Nature magazine.

Entity Name	Icahn School Of Medicine At Mount Sinai
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1275802811 PECOS PAC ID: 2264691070 Enrollment ID: O20120315000035

Chemists rationally design inhibitors against an RNA molecule that causes myotonic muscular dystrophy

U.S. District Court Judge approves amended settlement in WTC litigation

Dendritic-specific Golgi plays key role in early neuropathy of degenerative brain disease

A joint research team of DGIST have identified the early neuropathic mechanism of polyglutamine brain disease, one of the representative degenerative brain diseases, and suggested a way to restore.

Bees-Haus method of cell therapy for treating urethral stricture receives Japanese patent

Treating male urethral stricture with the patient's own buccal mucosal cells, encapsulated in a polymer scaffold as carrier, has been granted a patent in Japan.

Scientists can produce new proteins by following certain rules

Entity Name	Icahn School Of Medicine At Mount Sinai
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1750647152 PECOS PAC ID: 2264691070 Enrollment ID: O20130920000028

Chemists rationally design inhibitors against an RNA molecule that causes myotonic muscular dystrophy

U.S. District Court Judge approves amended settlement in WTC litigation

Dendritic-specific Golgi plays key role in early neuropathy of degenerative brain disease

A joint research team of DGIST have identified the early neuropathic mechanism of polyglutamine brain disease, one of the representative degenerative brain diseases, and suggested a way to restore.

Bees-Haus method of cell therapy for treating urethral stricture receives Japanese patent

Treating male urethral stricture with the patient's own buccal mucosal cells, encapsulated in a polymer scaffold as carrier, has been granted a patent in Japan.

Scientists can produce new proteins by following certain rules

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Fernando Ferrer is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Fernando Ferrer, MD 247 Route 100, Suite 1002, Somers, NY 10589-3231 Ph: (914) 962-8290	Fernando Ferrer, MD 100 Simsbury Rd, Suite 208, Avon, CT 06001-3793 Ph: (860) 409-0413

News Archive

Chemists rationally design inhibitors against an RNA molecule that causes myotonic muscular dystrophy

U.S. District Court Judge approves amended settlement in WTC litigation

Dendritic-specific Golgi plays key role in early neuropathy of degenerative brain disease

A joint research team of DGIST have identified the early neuropathic mechanism of polyglutamine brain disease, one of the representative degenerative brain diseases, and suggested a way to restore.

Bees-Haus method of cell therapy for treating urethral stricture receives Japanese patent

Treating male urethral stricture with the patient's own buccal mucosal cells, encapsulated in a polymer scaffold as carrier, has been granted a patent in Japan.

Fernando Ferrer, MD - Medicare Urology in Avon, CT

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medicare Reassignments

Chemists rationally design inhibitors against an RNA molecule that causes myotonic muscular dystrophy

U.S. District Court Judge approves amended settlement in WTC litigation

Dendritic-specific Golgi plays key role in early neuropathy of degenerative brain disease

Bees-Haus method of cell therapy for treating urethral stricture receives Japanese patent

Scientists can produce new proteins by following certain rules

Chemists rationally design inhibitors against an RNA molecule that causes myotonic muscular dystrophy

U.S. District Court Judge approves amended settlement in WTC litigation

Dendritic-specific Golgi plays key role in early neuropathy of degenerative brain disease

Bees-Haus method of cell therapy for treating urethral stricture receives Japanese patent

Scientists can produce new proteins by following certain rules

Chemists rationally design inhibitors against an RNA molecule that causes myotonic muscular dystrophy

U.S. District Court Judge approves amended settlement in WTC litigation

Dendritic-specific Golgi plays key role in early neuropathy of degenerative brain disease

Bees-Haus method of cell therapy for treating urethral stricture receives Japanese patent

Scientists can produce new proteins by following certain rules

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Chemists rationally design inhibitors against an RNA molecule that causes myotonic muscular dystrophy

U.S. District Court Judge approves amended settlement in WTC litigation

Dendritic-specific Golgi plays key role in early neuropathy of degenerative brain disease

Bees-Haus method of cell therapy for treating urethral stricture receives Japanese patent

Scientists can produce new proteins by following certain rules

Urology Doctors in Avon, CT